Accessibility: Skip TopNav
Nasdaq Welcomes Zealand Pharma (Nasdaq: ZEAL) to The Nasdaq Stock Market
Britt Meelby Jensen, President and CEO of Zealand Pharma A/S, celebrates Zealand Pharma's IPO at the Nasdaq MarketSite.
Format
JPEG
Source
Nasdaq, Inc.
Downloads
Original
Large
Medium
Small